Managing a safe laboratory for studying infectious diseases
Official title: BSL3 management and practice of infectious disease research at HTRL
Funded at University of Chicago · NIH-10910202 · Data updated 2026-11-12
This study is all about keeping a special lab safe and running smoothly so that scientists can research dangerous germs, like those that could come from bioterrorism or new viruses, to help us better understand and fight infectious diseases that can affect our health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,464,978 |
| NIH project number | 5UC7AI180312-02 |
| Project ID | NIH-10910202 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals involved in infectious disease management, public health professionals, and researchers in microbiology.
✕Less likely to help
Patients with non-infectious diseases or those not involved in research or public health may not receive direct benefits from this research.
What this research studies
This research focuses on maintaining and managing a Biosafety Level 3 (BSL3) laboratory dedicated to studying infectious diseases, particularly those that could arise from bioterrorism or emerging pathogens like the novel coronavirus. The project involves training professionals in biosafety practices and ensuring the safe operation of the laboratory, which is crucial for conducting research on disease-causing microbes and understanding how they affect human health. By leveraging existing expertise and resources, the laboratory aims to enhance our ability to detect and respond to infectious disease threats.
Why it matters
Potential benefit: If successful, this research could improve our preparedness and response to infectious disease outbreaks, ultimately protecting public health.
How similar studies have gone: Previous research in similar BSL3 facilities has shown success in advancing our understanding of infectious diseases and improving biosafety practices.
Where this research is happening
-
University of Chicago
Chicago, United States Active
Researchers
- Principal investigator: Missiakas, Dominique M. — University of Chicago
- Study coordinator: Missiakas, Dominique M.
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.